Lumio, Norwalito B.

HRN: 19-02-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2024
CEFTAZIDIME 1GM (VIAL)
08/09/2024
08/17/2024
IV
1gm
TID
Pneumonia
Waiting Final Action 
08/09/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/09/2024
08/16/2024
IV
4.5g
Q6
Pneumonia
Waiting Final Action 
08/09/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/09/2024
08/16/2024
ORAL
500mg
Q24
Pneumonia
Waiting Final Action 
08/21/2024
CO-AMOXICLAV 625MG (TAB)
08/21/2024
08/28/2024
PO
625mg
Tid
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: